These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28434260)

  • 1. Dapsone-associated fixed drug eruption.
    Garcia D; Cohen PR
    Expert Rev Clin Pharmacol; 2017 Jul; 10(7):717-725. PubMed ID: 28434260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone.
    Molinelli E; Paolinelli M; Campanati A; Brisigotti V; Offidani A
    Expert Opin Drug Metab Toxicol; 2019 May; 15(5):367-379. PubMed ID: 30943794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Generalized Exanthematous Pustulosis (AGEP) due to dapsone in a patient with leprosy.
    Narasimharao P; Pratap DV; Suneetha S
    Lepr Rev; 2009 Mar; 80(1):81-4. PubMed ID: 19472855
    [No Abstract]   [Full Text] [Related]  

  • 4. A double blow for a patient with leprosy: a reversal reaction and an adverse drug reaction.
    Thangaraju P; Venkatesan S
    Lancet; 2019 Oct; 394(10207):1450. PubMed ID: 31631856
    [No Abstract]   [Full Text] [Related]  

  • 5. Dapsone induced acute photosensitivity dermatitis; a case report and review of literature.
    De D; Dogra S; Kaur I
    Lepr Rev; 2007 Dec; 78(4):401-4. PubMed ID: 18309716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dapsone-induced photosensitivity: a rare clinical presentation.
    Kar BR
    Photodermatol Photoimmunol Photomed; 2008 Oct; 24(5):270-1. PubMed ID: 18811870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapsone and sulfapyridine.
    Paniker U; Levine N
    Dermatol Clin; 2001 Jan; 19(1):79-86, viii. PubMed ID: 11155588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review on Dapsone Hypersensitivity Syndrome Among Chinese Patients with an Emphasis on Preventing Adverse Drug Reactions with Genetic Testing.
    Wang N; Parimi L; Liu H; Zhang F
    Am J Trop Med Hyg; 2017 May; 96(5):1014-1018. PubMed ID: 28167593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity reactions to dapsone: a systematic review.
    Lorenz M; Wozel G; Schmitt J
    Acta Derm Venereol; 2012 Mar; 92(2):194-9. PubMed ID: 22307940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal dapsone hypersensitivity syndrome with hypothyroidism and steroid-induced diabetes mellitus.
    Pai S; Munshi R; Nayak C
    Indian J Pharmacol; 2017; 49(5):396-398. PubMed ID: 29515281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed genital drug eruption due to dapsone. A case report.
    Sinha MR
    Lepr India; 1982 Jan; 54(1):152-4. PubMed ID: 6212718
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal hypersensitivity vasculitis associated with dapsone.
    Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Rabel-Filho OC; Martini-Filho D; Fontes CJ
    Am J Kidney Dis; 2005 Oct; 46(4):e51-3. PubMed ID: 16183407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapsone 7.5% Gel: A Review in Acne Vulgaris.
    Al-Salama ZT; Deeks ED
    Am J Clin Dermatol; 2017 Feb; 18(1):139-145. PubMed ID: 28005194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary tract carcinoma in leprosy patients treated with dapsone for a long period.
    Hironaka K; Mizushima M; Tsuzi C; Makino H
    Nephron; 1997; 76(3):358-9. PubMed ID: 9226243
    [No Abstract]   [Full Text] [Related]  

  • 17. Dapsone-induced erythema multiforme with neutropenia in a patient with linear IgA dermatosis: case report and review of the literature.
    Urosevic-Maiwald M; Kerl K; Harr T; Bogdan Allemann I
    Int J Dermatol; 2013 Nov; 52(11):1369-71. PubMed ID: 23829595
    [No Abstract]   [Full Text] [Related]  

  • 18. The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions.
    Chen WT; Wang CW; Lu CW; Chen CB; Lee HE; Hung SI; Choon SE; Yang CH; Liu MT; Chen TJ; Fan WL; Su SC; Lin YY; Chang YC; Chung WH;
    J Invest Dermatol; 2018 Jul; 138(7):1546-1554. PubMed ID: 29458119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Onset Dapsone-induced Photosensitive Dermatitis: A Rare Side Effect of a Common Drug.
    Karjigi S; Murthy SC; Kallappa H; Kusuma MR; Reddy YN
    Indian J Lepr; 2015; 87(3):161-4. PubMed ID: 26999988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan.
    Sheen YS; Chu CY; Wang SH; Tsai TF
    J Dermatolog Treat; 2009; 20(6):340-3. PubMed ID: 19954390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.